Title
Category
Credits
Event date
Cost
Prescription Drug and Controlled Substance Abuse: Opioid Diversion and Best-Practice Prescribing
  • Drug Diversion
  • Prescribing: Controlled Substance(s)
  • 3.00 ANCC
$30.00
This 3-contact-hour continuing education course shows nurses and other healthcare practitioners how prescription drug abuse can be prevented and why it is so common. Learn more about the current opioid and prescribed drug abuse epidemic and challenges in managing chronic pain for a better patient outcome.Meets Florida, Massachusetts, Nevada, New Jersey, Rhode Island and Texas requirements.
Best-Practice Prescribing and Drug Diversion Training for West Virginia Nurses (3 Hours)
  • Drug Diversion
  • Pharmacology
  • 3.00 ANCC
$30.00
MANDATORY WEST VIRGINIA NURSING CEU. Fulfills the WV Board of Nursing requirement of 3 contact hours of continuing education on drug diversion and responsible prescribing of controlled substances. Per Chapter 30-1-7a, each nurse must complete 3 contact hours initially and then 1 contact hour, thereafter, annually of CE for drug diversion training, best-practice prescribing of controlled substances training and training on prescribing and administration of an opioid antagonist if they prescribe, administer or dispense controlled substances.
Health 2.0: Implications for Care
  • 3.00 AMA PRA Category 1 Credit™
  • 3.00 ANCC
  • 3.00 ASWB
$21.00
This course will provide an overview of Web 2.0 and how it is used in the health, social work, and mental health fields, referred to as Health 2.0. It will also explore how Health 2.0 affects access to health information and ultimately clients' healthcare decisions. Internet health information seeking patterns and practitioners' and clients' perceptions of the Internet as a source of health information will also be discussed.
Buprenorphine for Opioid Use Disorder
  • Buprenorphine
  • Opioid Use Disorder (OUD)
  • 2.00 AMA PRA Category 1 Credit™
$0.00
The United States is in the midst of an epidemic of opioid overdoses and overdose deaths. Multiple factors have contributed to this epidemic. “One aspect of managing this crisis is to increase the number of providers able to treat opioid use disorder with Medication for Addiction Treatment (or MAT).”This presentation will focus on the use of buprenorphine to treat opioid use disorder. The purpose of the program is to educate potential buprenorphine prescribers to encourage them to treat patients with opioid use disorder with buprenorphine.
Disrupting Bias in Healthcare
  • Implicit Bias
  • 1.00 AMA PRA Category 1 Credit™
$0.00
Implicit biases and microaggressions have been shown to impact healthcare in many areas including contributing to (1) inaccurate or compromised clinical assessments, (2) differences in treatment recommendations (3) differences in communication quality with patients and (3) erosion of trust between health professionals and patients.  Though they have a potentially dangerous and long-lasting impact on healthcare, research has demonstrated that impact of implicit bias can be mitigated with awareness, concern of impact, and intentionality for change.
Antiviral Selection and Management of Potential Drug-Drug Interactions for COVID-19 in an Outpatient Setting
  • Pharmacology
  • 0.70 AANP Contact Hours
  • 0.70 AANP Pharmacology Contact Hours
  • 0.75 AMA PRA Category 1 Credit™
$0.00
Enhance your knowledge of COVID-19 management for non-hospitalized patients with this comprehensive Q&A. Expert faculty have answered important questions on guideline recommendations for pharmacologic treatments and provided essential insights for navigating potential drug-drug interactions. Add this direct and practical resource to your clinical toolbox and feel equipped to treat COVID-19 in the outpatient setting. 
Gender Affirming Hormonal Care for the Primary Care Provider
  • Pharmacology
  • Gender-affirming Care
  • LGBTQ
  • 1.00 AANP Contact Hours
  • 1.00 AANP Pharmacology Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This engaging session explores primary care for gender-diverse individuals. Through practical case studies, clinicians will navigate gender-affirming hormone therapies (GAHTs), including the benefits, complications, and comprehensive care strategies for patients. Enhance your expertise in supporting diverse patient populations.
Bupe...There it is! Part I - Prescribing Basics | Palliative Care Educational Series (RECORDING)
  • Palliative Care
  • Buprenorphine
  • Opioid Use Disorder (OUD)
  • Pain Management
  • 1.00 AMA PRA Category 1 Credit™
$0.00
In this recorded Palliative Care Educational Series presentation, palliative care and addiction medicine specialist Dr. Janet Ho provides a comprehensive overview on the use of buprenorphine, a partial opioid agonist, for pain management and treatment of opioid use disorder. Dr. Ho begins with an overview of buprenorphine's pharmacology, including its unique properties as a partial agonist with a strong binding affinity to the mu-opioid receptor, its ceiling effect on respiratory depression, and its ability to reduce hyperalgesia and cravings. Dr.
Antimicrobial Stewardship: Improving Clinical Outcomes by Optimization of Antibiotic Practices
  • Antimicrobial Stewardship
  • 7.00 AMA PRA Category 1 Credit™
$0.00
Internet Enduring Material provided by Stanford University School of Medicine. Presented by the Division of Infectious Diseases and Geographic Medicine at Stanford University School of Medicine. Sponsored by the Stanford University School of Medicine.
Antibiotics in Office Practice
  • Pharmacology
  • 1.00 AANP Contact Hours
  • 1.00 AANP Pharmacology Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
$0.00
In this interactive and clinically focused presentation, we will delve into the challenges clinicians encounter when prescribing antibiotics, with a strong emphasis on the appropriate use of antibiotics for common outpatient indications. We will explore the integration of newly approved oral antibiotic agents, discuss the efficacy of oral vs intravenous antibiotics, and examine the appropriate duration of antibiotic therapy.

Pages